Jamjoom Pharmaceuticals Factory Co.
What Changed
Full IR Briefing →Company Overview
Leadership Team
Chief Executive Officer · Since Jan 1, 2021
Head of Business Development & Strategy and IR Director
Chief Executive Officer
Head of Manufacturing Operations
General Manager of Sales in Egypt and North Africa
Chief Financial Officer · Since Jan 1, 2013
General Manager Gulf, Levant & other Export Markets · Since Jan 5, 2025
General Manager Consumer Health Division
Global Manufacturing Officer · Since Apr 14, 2024
Head of Operations · Since Jan 1, 2021
Vice President KSA · Since Jan 1, 2025
General Manager Cardiometabolic & CNS · Since Feb 2, 2025
Corporate Human Resources Director · Since Jan 1, 2024
Chief Transformation & Marketing Officer · Since Jan 1, 2025
Sr. Director Business Development · Since Mar 19, 2024
Head of Legal Department · Since Jan 1, 2022
Board Secretary
Recent Announcements
No announcements yet.
Data Sources
See Data Freshness Monitor for platform-wide data quality.
Price Chart
Key Metrics
Governance Score
Moderate
8-factor live score
Dividend Safety
10/100
Management Credibility
Low
Accounting Quality
62/100
Caution: M-Score elevated
SouqData provides data for informational purposes only. This does not constitute financial advice, a personal recommendation, or an offer to buy or sell any security. Information may contain errors or be outdated. Always verify data independently and consult a licensed financial adviser before making investment decisions.
Frequently Asked Questions about Jamjoom Pharmaceuticals Factory Co.
Where is Jamjoom Pharmaceuticals Factory Co. listed?
Jamjoom Pharmaceuticals Factory Co. is listed on the Saudi Exchange (Tadawul) (TDWL) in Saudi Arabia under the ticker 4015. SouqData profiles its financials, board and shareholders from public exchange disclosures.
What sector is Jamjoom Pharmaceuticals Factory Co. in?
Jamjoom Pharmaceuticals Factory Co. (TDWL: 4015) is classified in the Health Care sector. This classification is what SouqData uses for its sector rankings and peer comparisons.
What is the market cap of Jamjoom Pharmaceuticals Factory Co.?
Jamjoom Pharmaceuticals Factory Co. (TDWL: 4015) has a market capitalisation of about $748M (USD), according to the latest market data held by SouqData. The figure moves daily with the share price.
How many directors are on the Jamjoom Pharmaceuticals Factory Co. board?
Jamjoom Pharmaceuticals Factory Co. has 10 current board members on record at SouqData, 2 of whom are classed as independent, according to the latest board data drawn from public disclosures.
Who is the chairman of Jamjoom Pharmaceuticals Factory Co.?
Mahmoud Yousuf Mohammed Salah Jamjoom is the chair of the Jamjoom Pharmaceuticals Factory Co. (TDWL: 4015) board, according to the latest board data held by SouqData from public exchange disclosures.
Jamjoom Pharmaceuticals Factory Co. vs sector peers
Health Care · small-cap · 5 peers shown| Company | Market cap (USD) | Dividend yield | Governance | Shariah |
|---|---|---|---|---|
| Jamjoom Pharmaceuticals Factory Co. (4015) | $748M | 2.68% | 45(D) | — |
| Dallah Healthcare Co. (4004 · TDWL) | $972M | 0.02% | 24(F) | — |
| Astra Industrial Group (1212 · TDWL) | $868M | 0.02% | 27(F) | — |
| Dr. Soliman Abdul Kader Fakeeh Hospital Co. (4017 · TDWL) | $561M | 0.01% | 24(F) | — |
| National Medical Care Co. (4005 · TDWL) | $446M | 1.44% | 15(F) | — |
| Almoosa Health Co. (4018 · TDWL) | $427M | 0.01% | 24(F) | — |
Auto-generated peer set — same GICS sector, comparable market-cap band. Governance score is the unified 8-factor model (independence, board size, CEO/chair separation, attendance, auditor, credentials, committees, pay transparency). Shariah uses AAOIFI Standard No. 21. View all 58 sector peers.
Unlock the full SouqData platform
Get unlimited access to 180+ insight pages, AI copilot, deep research reports, watchlists, portfolio tracking, and the full 210-column screener across 11 MENA exchanges.